Skip to main content
SpringerLink
Log in

Kalziumantagonisten in der Arrhythmiebehandlung

  • Conference paper
Ventrikuläre Herzrhythmusstörungen

Zusammenfassung

Die sog. Kalziumantagonisten (z. B. Verapamil, D600, Nifedipin, Prenyl-amin, Fendilin, Perhexilin, Diltiazem; s. [18]) hemmen am Herzen den langsamen Einwärtsstrom, der unter physiologischen Bedingungen im wesentlichen von Ca-Ionen (Ca2+) getragen wird. Ursache für diese Wirkung der Kalziumantagonisten ist die Blockade des „langsamen Kanals“, nicht aber der Bewegung des Kalziumions an sich.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anderson JL, Harrison DC, Meffin PJ, Winkle RA (1978) Antiarrhythmic drugs: Clinical pharmacology and therapeutic uses. Drugs 15:271

    Article  PubMed  CAS  Google Scholar 

  2. Antoni H (1971) Electrophysiological mechanisms underlying pharmacological models of cardiac fibrillation. Naunyn Schmiedebergs Arch Pharmacol 269:177

    Article  PubMed  CAS  Google Scholar 

  3. Antoni H (1978) Zur Pathogenese der Herzrhythmusstörungen bei Myokardinfarkt. ZFA (Stuttgart) 54:859

    CAS  Google Scholar 

  4. Antoni H, Tägtmeyer H (1965) Die Wirkung starker Ströme auf Erregungsablauf und Kontraktion des Herzmuskels. Beiträge zur Ersten Hilfe und Behandlung von Unfällen durch elektrischen Strom 4:1

    Google Scholar 

  5. Bachour G, Bender F, Hochrein H (1977) Antiarrhythmische Wirkungen und hämodyna-mische Reaktionen unter Verapamil bei akutem Herzinfarkt. Herz/Kreisl 9:89

    Google Scholar 

  6. Bailey JC, Elharrar V, Zipes DP (1978) Slow channel depolarization: mechanism and control of arrhythmias. Ann Rev Med 29:417

    Article  PubMed  CAS  Google Scholar 

  7. Bender F (1966) Zur Behandlung der Rhythmusstörungen des Herzens. Therapiewoche 16:529

    Google Scholar 

  8. Bender F, Kojima N, Reploh HD, Oelmann G (1966) Behandlung tachykarder Rhythmusstörungen des Herzens durch Beta-Rezeptorenblockade des Atrioventrikulargewebes. Med Welt 17:1120

    Google Scholar 

  9. Bigger JT, Dresdale RJ, Heissenbuttel RH, Weld FM, Wit AL (1977) Ventricular arrhythmias in ischemic heart disease: Mechanism, prevalence, significance, and management. Progr Cardiovasc Dis 19:255

    Article  Google Scholar 

  10. Chen CM, Gettes LS (1979) Effects of verapamil on rapid Na channel-dependent action potentials of K+-depolarized ventricular fibers. J Pharmacol Exp Ther 209:415

    PubMed  CAS  Google Scholar 

  11. Cranefield PF (1975) The conduction of the cardiac impulse. The slow response and cardiac arrhythmias. Futura, Mount Kisco, New York

    Google Scholar 

  12. Cranefield PF, Wit AL (1979) Cardiac arrhythmias. Ann Rev Physiol 41:459

    Article  CAS  Google Scholar 

  13. Cranefield PF, Wit AL, Hoffman BF (1973) Genesis of cardiac arrhythmias. Circulation 47:190

    PubMed  CAS  Google Scholar 

  14. Ehara T, Kaufmann R (1978) The voltage- and time-dependent effects of (−)-vera-pamil on the slow inward current in isolated cat ventricular myocardium. J Pharmacol Exp Ther 207:49

    PubMed  CAS  Google Scholar 

  15. Elharrar V, Gaum WE, Zipes DP (1977) Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs. Am J Cardiol 39:544

    Article  PubMed  CAS  Google Scholar 

  16. El-Sherif N, Lazzara R (1979) Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the “slow channel”. Circulation 60:605

    PubMed  CAS  Google Scholar 

  17. Fazzini PF, Marchi F, Pucci P, Ledda F, Mugelli A (1979) Effects of verapamil on ventricular premature beats of acute myocardial infarction. Am Heart J 98:816

    Article  PubMed  CAS  Google Scholar 

  18. Fleckenstein A (1977) Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann Rev Pharmacol Toxicol 17:149

    Article  CAS  Google Scholar 

  19. Fondacaro JD, Han J, Yoon MS (1978) Effects of verapamil on ventricular rhythm during acute coronary occlusion. Am Heart J 96:81

    Article  PubMed  CAS  Google Scholar 

  20. Grant AO, Katzung BG (1976) The effects of quinidine and verapamil on electrically induced automaticity in the ventricular myocardium of guinea pig. J Pharmacol Exp Ther 196:407

    PubMed  CAS  Google Scholar 

  21. Hasin Y, Rogel S (1976) Ventricular rhythms in acute myocardial infarction. Cardiology 61:195

    Article  PubMed  CAS  Google Scholar 

  22. Heng MK, Singh BN, Roche AHG, Norris RM, Mercer CJ (1975) Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram. Am Heart J 90:487

    Article  PubMed  CAS  Google Scholar 

  23. Kass RS, Tsien RW (1975) Multiple effects of calcium antagonists on plateau currents in cardiac Purkinje fibers. J Gen Physiol 66:169

    Article  PubMed  CAS  Google Scholar 

  24. Katz AM (1977) Physiology of the heart. Raven, New York

    Google Scholar 

  25. Kaufmann R (1977) Differenzierung verschiedener Kalzium-Antagonisten. Münch Med Wochenschr 119[Suppl 1]:6

    Google Scholar 

  26. Kaumann AJ, Aramendía P (1968) Prevention of ventricular fibrillation induced by coronary ligation. J Pharmacol Exp Ther 164:326

    PubMed  CAS  Google Scholar 

  27. Kohlhardt M (1979) Die Bedeutung von Slow-Response-Aktionspotentialen für die Erregung des Herzens. In: Antoni H, Bender F, Gerlach E, Schlepper M (eds) Herzrhythmusstörungen. Neue theoretische und klinische Aspekte, Schattauer, Stuttgart New York, p71

    Google Scholar 

  28. Kohlhardt M, Bauer B, Krause H, Fleckenstein A (1972) Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibers by the use of specific inhibitors. Pflügers Arch 335:309

    Article  PubMed  CAS  Google Scholar 

  29. Kupersmith J, Shiang H, Litwak RS, Herman MV (1976) Electrophysiologic effects of verapamil in canine myocardial ischemia. Am J Cardiol 37:149

    Article  Google Scholar 

  30. Melville KI, Shister HE, Huq S (1964) Iproveratril: Experimental data on coronary dilatation and antiarrhythmic action. Can Med Assoc J 90:761

    PubMed  CAS  Google Scholar 

  31. Naumann d’Alnoncourt C, Lüderitz B (1980) Elektrostimulation bei Tachyarrhythmien — Pathophysiologie und Therapie. Herz/Kreisl 12:145

    Google Scholar 

  32. Nawrath H, Ten Eick RE, McDonald TF, Trautwein W (1977) On the mechanism underlying the action of D-600 on slow inward current and tension in mammalian myocardium. Circ Res 40:408

    PubMed  CAS  Google Scholar 

  33. Opie LH (1980) Calcium antagonists. Lancet 1:806

    Article  PubMed  CAS  Google Scholar 

  34. Reimer KE, Lowe JE, Jennings RB (1977) Effect of the calcium antagonist verapamil on nécrosis following temporary coronary artery occlusion in dogs. Circulation 55:581

    PubMed  CAS  Google Scholar 

  35. Rodrigues-Pereira E, Viana AP (1968) The actions of verapamil on experimental arrhythmias. Arzneim Forsch 18:175

    CAS  Google Scholar 

  36. Rosen MR, Hoffman BF (1973) Mechanisms of action of antiarrhythmic drugs. Circ Res 32:1

    PubMed  CAS  Google Scholar 

  37. Rosen MR, Wit AL, Hoffman BF (1975) Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil. Am Heart J 89:665

    Article  PubMed  CAS  Google Scholar 

  38. Schamroth L, Krikler DM, Garrett C (1972) Immediate effects of intravenous verapamil in cardiac arrhythmias. Br Med J 1:660

    Article  PubMed  CAS  Google Scholar 

  39. Schmid JR, Hanna C (1967) A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol. J Pharmacol Exp Ther 156:331

    PubMed  CAS  Google Scholar 

  40. Scholz H (1980) Effects of beta- and alpha-adrenoceptor activators and adrenergic transmitter releasing agents on the mechanical activity of the heart. In: Szekeres L (ed) Adrenergic activators and inhibitors. Springer, Berlin Heidelberg New York (Handbook of experimental Pharamcology, vol LIV/1), p 651

    Chapter  Google Scholar 

  41. Schulz W, Kober G (1979) Stellenwert der Kalziumantagonisten in der Behandlung der koronaren Herzkrankheit. Intern Welt 7:237

    Google Scholar 

  42. Singh BN (1977) Antiarrhythmic effects of local anesthetics and calcium antagonists. Phar-mac Ther [B] 2:125

    CAS  Google Scholar 

  43. Singh BN, Collett JT, Chew CYC (1980) New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis 22:243

    Article  PubMed  CAS  Google Scholar 

  44. Singh BN, Ellrodt G, Peter CT (1978) Verapamil: A review of its pharmacological properties and therapeutic use. Drugs 15:169

    Article  PubMed  Google Scholar 

  45. Smith HJ, Singh BN, Nisbet HD, Norris RM (1975) Effects of verapamil on infarct size following experimental coronary occlusion. Cardiovasc Res 9:569

    Article  PubMed  CAS  Google Scholar 

  46. Spear JF, Horowitz LN, Hodess AB, McVaugh H, Moore EN (1979) Cellular electrophysiology of human myocardial infarction. 1. Abnormalities of cellular activation. Circulation 59:247

    PubMed  CAS  Google Scholar 

  47. Theisen K (1978) Medikamentöse Therapie tachykarder Herzrhythmusstörungen. Klin Wochenschr 56:153

    Article  PubMed  CAS  Google Scholar 

  48. Tritthart H, Volkmann R, Weiss R, Fleckenstein A (1973) Calcium-mediated action potentials in mammalian myocardium. Naunyn-Schmiedebergs Arch Pharmacol 280:239

    Article  PubMed  CAS  Google Scholar 

  49. Vohra JK (1977) Clinical use of verapamil. Drugs 13:219

    Article  PubMed  CAS  Google Scholar 

  50. Weidmann S (1955) The effect of the cardiac membrane potential on the rapid availability of the sodium-carrying system. J Physiol (Lond.) 127:213

    CAS  Google Scholar 

  51. Wende W, Bleifeld W, Meyer J, Stühlen HW (1975) Reduction of the size of acute, experimental myocardial infarction by verapamil. Basic Res Cardiol 70:198

    Article  PubMed  CAS  Google Scholar 

  52. Wit AL, Rosen MR, Hoffman BF (1974) Electrophysiology and pharmacology of cardiac arrhythmias. II. Relationship of normal and abnormal electrical activity of cardiac fibers to the genesis of arrhythmias. Am Heart J 88:515, 664, 798

    Article  PubMed  CAS  Google Scholar 

  53. Wolf R, Habel F, Witt E, Nötges A, Everling F, Hochrein H (1977) Wirkung von Verapamil auf die Hämodynamik und Größe des akuten Myokardinfarkts. Herz 2:110

    Google Scholar 

  54. Zipes DP, Troup PJ (1978) New antiarrhythmic agents. Amiodarone, aprindine, disopyra-mide, ethmozin, mexiletine, tocainide, verapamil. Am J Cardiol 41:1005

    Article  PubMed  CAS  Google Scholar 

  55. Zipes DP, Besch HR, Watanabe AM (1975) Role of the slow current in cardiac electrophysiology. Circulation 51:761

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie und Toxikologie, Abteilung III (Biochemische Pharmakologie), Medizinische Hochschule Hannover, Karl-Wiechert-Allee 9, D-3000, Hannover 61, Deutschland

    Prof. Dr. H. Scholz

Authors
  1. Prof. Dr. H. Scholz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik I der Universität München, Klinikum Großhadern, Marchioninistraße 15, D-8000, München 70, Deutschland

    Berndt Lüderitz

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Scholz, H. (1981). Kalziumantagonisten in der Arrhythmiebehandlung. In: Lüderitz, B. (eds) Ventrikuläre Herzrhythmusstörungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67951-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67951-3_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-67952-0

  • Online ISBN: 978-3-642-67951-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation